Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

IPSC Century Therapeutics Inc

3,13

0,09 (2,96%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Exhibit 24

Century Therapeutics (NASDAQ:IPSC)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Century Therapeutics Charts.

Century Therapeutics (NASDAQ:IPSC)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Century Therapeutics Charts.

News Century Therapeutics Inc

Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
Freitag 10 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 9 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Donnerstag 9 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 6 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Dienstag 23 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Donnerstag 11 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Montag 8 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
Montag 25 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Century Therapeutics Inc News-Artikel

Deutsche Telekom

Deutsche Telekom (QX)

Financial Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen